TVM V LIFE SCIENCE VENTURES GMBH & CO KG's Net Worth
$58.5 Million
Who is TVM V LIFE SCIENCE VENTURES GMBH & CO KG?
TVM V LIFE SCIENCE VENTURES GMBH & CO KG has an estimated net worth of $58.5 Million. This is based on reported shares across multiple companies, which include ENANTA PHARMACEUTICALS INC, Sirtris Pharmaceuticals, Inc., Coley Pharmaceutical Group, Inc., bluebird bio, Inc., Pharmasset Inc, and ARGOS THERAPEUTICS INC.
SEC CIK
TVM V LIFE SCIENCE VENTURES GMBH & CO KG's CIK is 0001183073
Past Insider Trading and Trends
2013 was TVM V LIFE SCIENCE VENTURES GMBH & CO KG's most active year for acquiring shares with 15 total transactions. TVM V LIFE SCIENCE VENTURES GMBH & CO KG's most active month to acquire stocks was the month of May. 2014 was TVM V LIFE SCIENCE VENTURES GMBH & CO KG's most active year for disposing of shares, totalling 27 transactions. TVM V LIFE SCIENCE VENTURES GMBH & CO KG's most active month to dispose stocks was the month of February. 2013 saw TVM V LIFE SCIENCE VENTURES GMBH & CO KG paying a total of $1,861,286.00 for 4,963,752 shares, this is the most they've acquired in one year. In 2014 TVM V LIFE SCIENCE VENTURES GMBH & CO KG cashed out on 1,179,335 shares for a total of $45,914,359.87, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ENANTA PHARMACEUTICALS INC (ENTA) Snapshot price: $11.54
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
| -9.86% | -439.33K |
$38.82 | -$17,053,133.96 | 4.01M |
Mar 3 - Mar 4
| |||
Form 4
| -9.64% | -439.33K |
$38.82 | -$17,053,133.96 | 4.12M |
Mar 3 - Mar 4
| |||
Form 4
| -4.74% | -230.19K |
$39.43 | -$9,012,968.30 | 4.62M |
Feb 25 - Feb 26
| |||
Form 4
| -1.20% | -60.48K |
$39.75 | -$2,393,270.65 | 4.98M |
Feb 21 - Feb 24
| |||
Form 4
| -0.39% | -10.00K |
$40.19 | -$401,853.00 | 2.52M |
Feb 18
| |||
Form 4
| +431.31% | 2.53M |
$14.00 |
—
| 3.12M |
Mar 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
bluebird bio, Inc. (BLUE) Snapshot price: $0.53
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.25M |
—
|
—
| 2.25M |
Jun 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Sirtris Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.58M |
—
|
—
| 2.58M |
May 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Coley Pharmaceutical Group, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.96M |
—
|
—
| 1.96M |
Aug 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Pharmasset Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||